Correlation Between Bio Gene and Bluescope Steel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and Bluescope Steel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Bluescope Steel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and Bluescope Steel, you can compare the effects of market volatilities on Bio Gene and Bluescope Steel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Bluescope Steel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Bluescope Steel.

Diversification Opportunities for Bio Gene and Bluescope Steel

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Bio and Bluescope is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Bluescope Steel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluescope Steel and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Bluescope Steel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluescope Steel has no effect on the direction of Bio Gene i.e., Bio Gene and Bluescope Steel go up and down completely randomly.

Pair Corralation between Bio Gene and Bluescope Steel

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the Bluescope Steel. In addition to that, Bio Gene is 2.24 times more volatile than Bluescope Steel. It trades about -0.2 of its total potential returns per unit of risk. Bluescope Steel is currently generating about 0.14 per unit of volatility. If you would invest  2,053  in Bluescope Steel on August 31, 2024 and sell it today you would earn a total of  159.00  from holding Bluescope Steel or generate 7.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bio Gene Technology  vs.  Bluescope Steel

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Bluescope Steel 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bluescope Steel are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain essential indicators, Bluescope Steel may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Bio Gene and Bluescope Steel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and Bluescope Steel

The main advantage of trading using opposite Bio Gene and Bluescope Steel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Bluescope Steel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluescope Steel will offset losses from the drop in Bluescope Steel's long position.
The idea behind Bio Gene Technology and Bluescope Steel pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets